Milestone Pharmaceuticals's total assets for Q4 2025 were $113.56M, an increase of 29.41% from the previous quarter. MIST total liabilities were $71.79M for the fiscal quarter, a 6.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.